FDA Approved: TOREMIFENE CITRATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for toremifene citrate from Rising Pharma Holdings, Inc., under an Abbreviated New Drug Application (ANDA 208813).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Toremifene citrate (toremifene citrate)

Snippet

SUPPL AP for TOREMIFENE CITRATE (TOREMIFENE CITRATE)